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ABSTRACT
Leprosy is a contagious and chronic systemic granulomatous disease caused by Mycobacterium leprae (Hansen’s baci-
llus). It is transmitted from person to person and has a long incubation period (between two and six years). The disease 
presents polar clinical forms (the “multibacillary” lepromatous leprosy and the “paucibacillary” tuberculoid leprosy), as 
well as other intermediate forms with hybrid characteristics. Oral manifestations usually appear in lepromatous leprosy 
and occur in 20-60% of cases. They may take the form of multiple nodules (lepromas) that progress to necrosis and 
ulceration. The ulcers are slow to heal, and produce atrophic scarring or even tissue destruction. The lesions are usually 
located on the hard and soft palate, in the uvula, on the underside of the tongue, and on the lips and gums. There may 
also be destruction of the anterior maxilla and loss of teeth. The diagnosis, based on clinical suspicion, is confirmed 
through bacteriological and histopathological analyses, as well as by means of the lepromin test (intradermal reaction 
that is usually negative in lepromatous leprosy form and positive in the tuberculoid form). The differential diagnosis 
includes systemic lupus erythematosus, sarcoidosis, cutaneous leishmaniasis and other skin diseases, tertiary syphilis, 
lymphomas, systemic mycosis, traumatic lesions and malignant neoplasias, among other disorders. Treatment is difficult 
as it must be continued for long periods, requires several drugs with adverse effects and proves very expensive, particu-
larly for less developed countries. The most commonly used drugs are dapsone, rifampicin and clofazimine. Quinolones, 
such as ofloxacin and pefloxacin, as well as some macrolides, such as clarithromycin and minocyclin, are also effective. 
The present case report describes a patient with lepromatous leprosy acquired within a contagious family setting during 
childhood and adolescence.
Key words: Mycobacterium leprae, lepromatous leprosy, tuberculoid leprosy, differential diagnosis.
RESUMEN
La lepra es una enfermedad granulomatosa sistémica crónica y contagiosa, producida por Mycobacterium leprae (bacilo 
de Hansen). Se transmite de persona a persona y tiene un largo período de incubación (entre 2 y 6 años). Existen dos 
formas clínicas polares: lepra lepromatosa (multibacilar) y lepra tuberculoide (paucibacilar), con otras formas intermedias 
de características híbridas. Las manifestaciones orales suelen aparecer en la lepra lepromatosa y se producen en el 20 al 
60% de los casos. Pueden tratarse de nódulos múltiples (lepromas), que progresan a necrosis y ulceración. Las úlceras 
curan con lentitud; forman cicatrices atróficas o pueden causar la destrucción del tejido. Las lesiones suelen localizarse 
en el paladar duro y blando, en la úvula, en el dorso de la lengua, en los labios y en las encías. También puede producirse 
destrucción de la parte frontal del maxilar y pérdida de dientes. El diagnóstico, basado en la presunción clínica, se com-
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INTRODUCTION
Leprosy is a contagious and chronic systemic granuloma-
tous disease caused by Mycobacterium leprae (Hansen’s 
bacillus). It is transmitted from person to person and has 
a long incubation period (between two and six years). The 
mycobacterium has a preference for peripheral tissue, as 
it appears to survive better at a temperature close to 30ºC 
rather than 37ºC. Hence it affects the skin, peripheral nerves, 
the mucosa of the upper airways and other tissues such as 
bone and some viscera (1-3). The disease presents polar 
clinical forms (the “multibacillary” lepromatous leprosy and 
the “paucibacillary” tuberculoid leprosy), as well as other 
intermediate forms with hybrid characteristics (Table 1). 
Oral manifestations usually appear in lepromatous leprosy 
and occur in 20-60% of cases. They may take the form of 
multiple nodules (lepromas) that progress to necrosis and 
ulceration.
 The ulcers are slow to heal, and produce atrophic scarring 
or even tissue destruction. The lesions are usually located on 
the hard and soft palate, in the uvula, on the underside of 
the tongue, and on the lips and gums. There may also be des-
truction of the anterior maxilla and loss of teeth (1,2,4,5). 
The diagnosis, based on clinical suspicion, is confirmed 
through bacteriological and histopathological analyses (in 
which non-caseating granulomas are observed), as well as 
by means of the lepromin test (intradermal reaction that is 
usually negative in lepromatous leprosy form and positive in 
the tuberculoid form) (6). The differential diagnosis includes 
systemic lupus erythematosus, sarcoidosis, cutaneous leish-
maniasis and other skin diseases, tertiary syphilis, cicatricial 
pemphigoid, lethal midline granuloma, lymphomas, syste-
mic mycosis, traumatic lesions and malignant neoplasias, as 
well as peripheral nerve pathology such as syringomyelia, 
among other disorders (2,6).
pleta con el examen bacteriológico e histopatológico, así como mediante la prueba de la lepromina (intradermorreacción 
que suele ser negativa en la forma lepromatosa y positiva en la tuberculoide). El diagnóstico diferencial incluye lupus 
eritematoso sistémico, sarcoidosis, leishmaniasis cutánea y otras enfermedades de la piel, sífilis terciaria, linfomas, micosis 
sistémicas, lesiones traumáticas y neoplasias malignas, entre otras. El tratamiento es difícil, ya que ha de prolongarse 
durante mucho tiempo, requiere varios fármacos con efectos adversos y resulta muy caro, sobre todo para los países 
menos desarrollados. Los de empleo más frecuente son la dapsona, la rifampicina y la clofazimina. También son eficaces 
las quinolonas, como ofloxacino y pefloxacino, así como algunos macrólidos, como la claritromicina y la minociclina. 
En el presente trabajo se expone el caso clínico de un paciente afecto de lepra lepromatosa, adquirida en un ambiente 
familiar de contagio durante la infancia y adolescencia.
Palabras clave: Mycobacterium leprae, lepra lepromatosa, lepra tuberculoide, diagnóstico diferencial.
Characteristic TL BT B BL LL 
Rhinitis No No No Occasional Yes 
Maxillary 
destruction No No No No Yes 
Ocular
involvement No No No Rare Yes 
Testicular
involvement No No No Rare Frequent 
Skin lesions Isolated Multiple, satellite 
Numerous,
bilateral 
Numerous,
bilateral, 
homogeneous
Numerous
and
notable
(leonine 
facies) 
Anaesthesia Notable Notable Less than in TL
Much less 
than in TL Minimal 
Reaction to 
lepromin Notable Mild Variable Negative Negative 
Granulomatous
inflammation Notable Moderate 
Some 
characteristics No No 
Bacilli in the 
lesions Rarely Few Moderate Abundant Teeming 
TL = Tuberculoid leprosy; BT = Borderline tuberculoid; B = Borderline; BL = Borderline leproma-
tous; LL = Lepromatous leprosy.
Table 1. Clinical and immunological differences between the different clinical forms of leprosy (4).
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Treatment is difficult as it must be continued for long pe-
riods, requires several drugs with adverse effects and proves 
very expensive, particularly for less developed countries. The 
most commonly used drugs are dapsone, rifampicin and 
clofazimine. Quinolones, such as ofloxacin and pefloxacin, 
as well as some macrolides, such as clarithromycin and 
minocyclin are also effective (6).
Evolution of the disease: Patients with lepromatous leprosy 
are highly infectious, although most exposed immunocom-
petent individuals do not contract the disease. Around 
one-third of people with leprosy present the first clinical 
manifestations during childhood. The incubation period of 
the disease may last up to six years. Once signs have appeared 
the disease will generally progress slowly unless treated. Its 
preference for cooler anatomical regions means that vital 
organs are usually preserved, but also makes leprosy a di-
sease that slowly destroys the distal areas of fingers and toes 
and causes nasal and facial deformities that lead to social 
marginalization. Local pyogenic infections, secondary to 
skin ulcers, complicate and exaggerate these alterations. 
Despite these problems the tendency of the disease to pre-
serve the main viscera means that life expectancy is barely 
reduced. Certain complications, such as pyogenic infection 
with abscess formation and sepsis, may produce an abrupt 
and fatal change in the disease course. 
Although the disease is uncommon in our milieu the rising 
immigration of recent years is good reason to take it into 
consideration. Therefore, it seemed of interest to review the 
topic by means of a highly representative clinical case.
CASE REPORT
Male patient aged 65 with no known allergies; he smokes 
twenty cigarettes a day and has a history of moderate alco-
hol abuse. He attended a long-stay unit during the summer 
of 2005 for a limited period (two months) in order to provide 
family respite.
Family history: 
Leprous family environment, in which the patient’s mother 
and three older siblings suffered from lepromatous leprosy, 
of similar presentation to that in the present report; all these 
relatives are now dead. This history does not seem to have 
affected the father or the patient’s younger sister, who are 
still alive.
Pathological history:
- Lepromatous leprosy diagnosed forty years previously. 
Multiple amputations (bilateral metacarpophalangeal, left 
metatarsophalangeal and nose due to relapsing infection of 
the septum, performed during the active phase of the disea-
se) (Figure 1) secondary to the leprous infection. Without 
anti-leprosy treatment since 1994 (due to negativization).
- Type II diabetes mellitus, which debuted in 1994. This is 
treated with NPH insulin. Presence of retinopathy, nephro-
pathy and dysautonomia.
- He presented a secondary bilateral amaurosis (leukocoria).
- In 2001 he suffered an important dysphagia, which was 
diagnosed as oesophageal stenosis, possibly due to gastroe-
sophageal regurgitation (of peptic origin).
Fig. 1. Leonine facies, characteristic of lepromatous 
leprosy. Note the nasal destruction, the lack of eye-
brow hair and eyelashes, the altered pigmentation 
and ocular alterations.
Fig. 2. Detail of the loss of upper incisors and nose.
Fig. 3. Photograph of the inside of the oral cavity; note the 
melanin pigmentation in the hard palate.
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- GGT and AP enzyme levels were elevated on the usual 
tests, which also revealed a microcytic anaemia. He was a 
carrier of the hepatitis C virus (HCV).
Current disease status: 
General physical examination showed the patient to be 
conscious and oriented. His skin was dry, pale and sclerotic. 
No adenopathies were palpated. The bilateral amaurosis 
and hypoacusia were noted. He also had problems swa-
llowing and presented solid and liquid dysphagia. He had 
spontaneous mobility of the extremities, where examination 
revealed the amputation of  fingers and toes of  the left 
foot, as well as the supracondylar amputation of the right 
lower extremity. There were suppurating ulcers on the right 
trochanter and at the head of the left fibula. He suffered 
from protein-energy malnutrition. He lives with his wife, a 
daughter and five grandchildren. He is being monitored by 
his general practitioner and receives domiciliary care for his 
left knee lesions and diabetes.
Facial and oral examination:
- Total facial deformation as a result of the lepromatous le-
sions and amputation of the nose: leonine facies (Figure 1).
- Numerous smooth perioral, hyperpigmented, polymor-
phous and poorly defined skin lesions were observed, and 
these invaded the lip vermillion and disappeared at the 
intraoral mucosa. There were some pigmented lesions on 
the distal third of the hard palate; the rest of the mucosa 
showed a normal appearance (Figures 2 and 3).
- The patient was sensitive to touch on all the mucosa and 
no subcutaneous granulomas were noted.
- The nasal septum was perforated, but there was no palate 
perforation or destruction of the soft parts (uvula, tongue, 
etc.).
- His dental health was very poor and revealed multiple 
caries and root remains, missing teeth (upper arcade prac-
tically edentulous) and gingivitis due to accumulation of 
bacterial plaque secondary to poor hygiene, which was partly 
determined by the amputations of the extremities.
The patient’s quality of  life was determined by his do-
miciliary situation and low socioeconomic status. This 
presented an obstacle in terms of following an adequate 
dental treatment.
Laboratory tests: 
Blood tests upon admission corroborated the anaemic state 
and the hepatic and renal alterations indicated previously. 
Secretion cultures from the ulcers on the lower extremities 
(right trochanter and head of the left fibula) were positive 
for Staphylococcus aureus.
Treatment plan upon discharge: 
Administration of paracetamol, haloperidol, NPH insulin 
and rohypnol. Diet to include carbohydrate monitoring 
and dietary supplements. The diabetes and anaemia to be 
monitored by the general practitioner, and the hepatopathy 
by a digestive specialist. Domiciliary care to be arranged for 
treating the ulcers. He was advised to see a dental specialist 
in order to have the root remains removed, and it was ex-
plained to him that having full dental prostheses (upper and 
lower) fitted would help restore his masticatory function.
DISCUSSION
- Facial alterations: Lepromatous leprosy usually begins 
in the form of chronic rhinitis. The symptoms are often so 
non-specific that the disease is not suspected prior to the 
appearance of skin lesions. The nasal mucosa become ulce-
rated and form scabs. These lesions sometimes bleed to the 
extent that medical attention is required. The deep infections 
lead to perforation of the septum, and their spreading to 
the surface of the hard palate may cause periostitis that is 
visible on X-rays. From the clinical point of view the greater 
evidence of pathology appears when the nasal bones, the 
nasal spine and even the midline maxillary region become 
affected; the erosion or complete destruction of the latter 
leads to tissue collapse, with sinking and spreading of the 
overlying skin and other soft tissues (saddle nose). This 
external soft tissue deformity constitutes one of the main 
facial alterations seen in patients with leprosy (1). The na-
sal secretions are literally teeming with leprous bacilli, and 
hence airborne dissemination, via sneezing, would seem to 
be the most likely way for leprosy to be spread nowadays. 
This rhinomaxillary syndrome only corresponds to the 
lepromatous form of leprosy (7), which is that suffered by 
the patient described here (Figure 1) and, most likely, was 
what affected his close relatives. At some undetermined 
point the patient suffers an initial bacillaemia, which may 
be repeated through recurrent episodes or progress toward 
a continuous bacteraemia. Multiple organs are exposed to 
the bacilli during these episodes. The circulating bacteria are 
so abundant that they can be detected in peripheral blood 
samples. However, those which settle in the internal organs 
are usually effectively eliminated by macrophages. As these 
bacteria multiply more in cooler areas the pattern of infec-
tion is usually focussed on the skin, superficial cutaneous 
structures (especially peripheral nerves), the eyes and the 
testicles. The facial skin shows areas of localized swelling, 
with deep furrows between them. The resulting nodules 
may become ulcerated. The swollen upper eyelids create a 
sleepy appearance and the repercussions in the supraorbital 
tissues usually lead to the loss of eyebrow hair, particularly 
in lateral areas. The subsequent damage to the sclera and iris 
may produce blindness. This nodular dermal appearance, 
often referred to as leonine facies, is another facial deformity 
characteristic of leprosy (1,8). The patient reported here 
suffered both bilateral blindness and leonine facies (Figure 
1). Lepromatous rhinitis may spread to the maxilla and be 
complicated by secondary pyogenic infections. Beginning 
at the midline, the maxillary bone begins to erode to the 
extent that the palate becomes perforated. This leads to loss 
of periodontal support for the upper middle incisors, which 
eventually fall out. In very advanced cases this process may 
spread to the sides and even reach the canine teeth. This loss 
of maxillary bone structures and teeth constitutes another 
characteristic facial alteration in leprosy (4), which in the 
case of our patient contributed to the leonine appearance 
of the lip (Figure 2).
- Nerve lesions: The peripheral nerves are usually affected 
by the bacillus in lepromatous leprosy. A hard and rigid 
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irregular nerve trunk is sometimes observed in the more 
superficial areas of the elbow (cubital nerve) or at the head 
of the fibula (peroneal nerve). However, the absence of a 
granulomatous form or inflammatory response reduces 
the tissue destruction characteristic of  the tuberculoid 
form. Hence the leprous bacilli may form large clusters 
in the nerve sheath, and in some patients this may at first 
lead to hyperaesthesia. The persistence of the bacteria and 
the subsequent destruction of nerve fibres are the cause of 
anaesthesia in hands and feet (1,9). This was not the case of 
the patient reported here, who maintained sensitivity.
- Skin lesions: In addition to the facial lesions described 
above it is common to find multiple skin macules in cooler 
areas of the body (extremities, buttocks). These are hypopig-
mented in dark-skinned people and erythematous in those 
with light skin. Their border is much less defined than in 
the tuberculoid form of leprosy. Although the trunk may be 
affected, few lesions are generally observed in this region (1). 
Our patient showed generalized changes in pigmentation, 
as can be seen in the figures.
- Bone lesions: In only 5% of hospitalized patients are the 
bones directly invaded by the bacilli. This invasion usually 
occurs indirectly, via lesions in the surrounding soft tissues 
or, less often, via the blood. In other cases the bone invol-
vement is secondary to peripheral neuropathy. The skin 
areas anaesthetised by the nerve infection are susceptible 
to tissue infection. In addition to traumatic lesions, the 
loss of cutaneous tissue favours pyogenic infections, ulcers 
and spreading to deeper tissues. This leads to arthritis and 
septic osteomyelitis of  non-leprous origin, accompanied 
by bone destruction and compromised movement due to 
muscular paralysis (also secondary to nerve the damage), 
which results in osteoporosis and bone atrophy. The phalanx 
and metacarpal or metatarsal bones are often affected, with 
marked shortening that may leave only a stump (1).
- Immunology: The clinical forms of leprosy depend heavily 
on the patient’s immunological state, which can be determi-
ned by the lepromin test (Mitsuda and Hayashi test). This 
consists in the intradermal injection of lepromin (extract of 
the leprous bacillus taken from sick patients). It is usually 
negative in lepromatous leprosy and positive in the tuber-
culoid form. However, as positive results are also obtained 
in patients without leprosy this test only serves to assess the 
immunological state in already-diagnosed patients (1,6). 
Leprous patients with a positive Mitsuda reaction usually 
present a histological tissue reaction similar to that found 
in tuberculosis, and hence the name give to this clinical 
form is tuberculoid leprosy. The lepromin reaction and 
histology indicate that these patients show a cell-mediated 
immune response, or delayed hypersensitivity, as occurs in 
tuberculosis. As few bacilli are found in the lesions of this 
clinical form it is known as paucibacillary. It is believed 
that these patients are much less contagious than those 
with lepromatous leprosy (1,6). In contrast, patients with a 
negative Mitsuda reaction show minimal resistance to the 
action of mycobacteria, which grow in a relatively unres-
tricted fashion and form large bacterial clusters that prove 
to be highly infectious. This multibacillary clinical form is 
known as lepromatous leprosy. Laboratory studies suggest 
there to be a defective T-cell response to the antigens of 
M. leprae (10) and other micro-organisms (11). The reason 
for the different immune response of the two clinical forms 
remains unclear. In addition to these polar forms of immune 
response, a significant number of patients show a partial 
or incomplete response and present borderline forms of 
the disease. In 1980, the WHO attempted to describe these 
degrees of semi-quantitative response, designating them as 
borderline tuberculoid (BT) and borderline lepromatous 
(BL) (12). Although the position of a given patient on this 
spectrum is relatively stable the immune response which cha-
racterises tuberculoid leprosy may deteriorate in untreated 
patients, especially in those who suffer malnutrition or other 
infections (13). Under these circumstances the clinical form 
begins to acquire certain lepromatous characteristics, with 
aspects of BL, the intermediate form or, more rarely, BT. It is 
very rare for the reverse trend to be observed spontaneously, 
and it is only seen in treated patients (1).
- Interactions between leprosy and tuberculosis: The anti-
bodies produced by a given bacterial species may be capable 
of combining with membrane receptors of other species. 
This notion of cross reactions is not unique, although it is 
better documented in examples of humoral rather than cell 
immunity. It is clear that the patient’s immune state is of key 
importance as regards the clinical manifestations of leprous 
infection and plays a role in the relationship between leprosy 
and tuberculosis. Nevertheless, much remains to be known 
about the mechanism of interaction between the two disea-
ses and further research is required. Although both leprosy 
and tuberculosis were more common in the past they have 
never completely disappeared, as is illustrated by numerous 
publications throughout history. In many places (where po-
verty abounds) they continue to be endemic (14), although 
isolated (in the case of leprosy) or not-so-isolated cases may 
still appear in developed countries, as has occurred with 
tuberculosis in the context of the Aids pandemic.
It should also be borne in mind that the characteristics of 
leprous lesions are not always as evident as those described 
here. Depending on the stage at which they are diagnosed, 
the appearance of these lesions may be similar to those of 
other conditions and this makes the differential diagnosis 
difficult (2,6,14). Hopefully the present report will serve to 
remind us that this stigmatized pathology should not be 
forgotten.
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